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 Cachexia is a systemic metabolic syndrome characterized by progressive muscle 
wasting. Cachectic muscle wasting presents as a comorbidity with pathological illnesses like 
cancer, chronic inflammation, and type 2 diabetes. The development of cachexia complicates 
treatment of these diseases and worsens clinical outcomes. Thus, it has become the focus of 
intense investigation. While many of the upstream mechanisms that propagate cachectic 
muscle wasting have been brought to light, little is known of the downstream mechanisms which 
would be more clinically relevant. Here, we have adopted a Drosophila model of cachectic 
muscle wasting to elucidate a novel role of the transcriptional regulator, cabut (cbt), in selective 
degeneration of flight muscles over jump muscles. We report that cbt impairs mitochondrial 
function and expends vital glycogen stores from the flight muscles. Our results contend that the 
resilience of the jump muscles to degeneration resides in their low oxidative output and sporadic 
energetic requirements. Furthermore, we have implicated cbt as a positive regulator of jump 











Cachexia is a lethal metabolic syndrome 
Muscle wasting is a loss of muscle mass and function that manifests through atrophy 
(muscle fiber shrinkage) and fiber degeneration (fiber loss) (Bonaldo and Sandri 2013). The 
process of muscle wasting is a natural part of aging, but it can be accelerated through inactivity 
or disease. Cachexia is a metabolic syndrome characterized by progressive wasting of skeletal 
muscle (Langstein and Norton 1991). Cachectic muscle wasting is a collateral condition 
inducible by numerous pathological conditions such as cancer, chronic inflammation, congestive 
heart failure, and diabetes (Saitoh et al. 2017; Sayer et al. 2005). In many cases, cachexia 
becomes the primary cause of death. Sudden cardiac failure and respiratory failure (inability to 
support breathing due to weak diaphragm and intercostal muscles) comprise some of the most 
common causes of death in cachectic patients (Porporato 2016).  
It is estimated that half of all cancer patients develop cachexia (Argilés et al. 2014). 
Strikingly, cachexia is attributed as the immediate cause of death in 20% to 40% of late-stage 
cancer patients (Fox et al. 2009). Like all cachectic conditions, cancer cachexia (simply, 
cachexia in the presence of a tumor) is complex and cannot be attributed to a single defect. 
Impaired cell signaling in pathways regulating inflammatory mechanisms, autophagy, nutrient 
response, glucose metabolism, proteostasis, and other physiological functions has been 
implicated in the development of cancer cachexia (Aoyagi et al. 2015). Since muscle wasting is 
largely responsible for the morbid effects of cachexia, there is a continuing interest from the 
research community to further reveal molecular mechanisms that make muscles sensitive to 






The insulin/insulin-like signaling pathway and its involvement in muscle wasting 
There is reason to believe that dysregulated insulin/insulin-like growth factor-1 (IGF-1) 
signaling (IIS) has a major role in the pathogenesis of cancer cachexia (Lundholm et al. 1978; 
Costelli et al. 2006). Insulin and IGF-1 belong to heavily conserved evolutionary lineages of 
peptide hormones (Pertseva and Shpakov 2002). The most well-known function of insulin is to 
regulate systemic glucose homeostasis by both stimulating glucose uptake by cells and 
suppressing glucose synthesis in the liver (Weiss et al. 2014). A less appreciated, but equally 
vital function of insulin is to promote protein synthesis and inhibit protein degradation in muscles 
(Meek et al. 1998). IGF-1 regulates muscle proteostasis in similar anticatabolic fashion 
(Goldspink 1999). In vivo experiments in rodents have demonstrated hypertrophic effects of 
IGF-1, and in vitro studies found that IGF-1 promotes human myotube hypertrophy in cell 
cultures (Barton-Davis et al. 1998; Jacquemin et al. 2004). In mice, insulin receptor (IR) 
knockdown causes skeletal muscle wasting, likely due to atrophy caused by reduced protein 
synthesis. (O’Neill et al. 2010). Clearly, the IIS pathway has critical roles in metabolism and 
muscle mass maintenance that, if disrupted, could lead to cachectic muscle wasting. 
Effectors of the insulin/insulin-like signaling pathway in muscle wasting 
There has been considerable effort to resolve the molecular mechanisms downstream of 
IIS that lead to cachexia. Insulin/IGF-1 binding to IR and IGF1R induces similar downstream 
signals through the PI3K/Akt and MAPK pathways (Belfiore et al. 2009; Boucher et al. 2014). 
Activated PI3K phosphorylates the Ser/Thr kinase, Akt, which can then suppress nuclear 
translocation of Forkhead box O (FoxO) transcription factors through inhibitory phosphorylation 
events. FoxO is the main activator of gene expression under negative regulation by IIS. FoxO 
transcription factors induce expression of muscle-specific E3 ubiquitin ligases which mediate 
muscle atrophy by conjugating ubiquitin to protein substrates, thereby targeting them for 




when IIS is suppressed, FoxO may contribute to cachectic muscle wasting through 
enhancement of protein degradation. Indeed, expression of FOXO1 in transgenic mice was 
shown to reduce skeletal muscle mass. Moreover, these mice had reduced capacity for glucose 
metabolism and reduced quantities of red muscle fibers (Kamei et al. 2004). 
Akt can also induce activity of the mechanistic target of rapamycin (mTOR). The most 
well described function of mTOR is to negatively regulate the eukaryotic translation initiation 
factor 4E (eIF4E)-binding protein 1 (4E-BP1). 4E-BP1 is thought to repress protein synthesis by 
binding eIF4E, thereby preventing eIF4E from associating with its translational complex 
(Gingras et al. 1998). Evidence suggests that mTOR dissociates the inhibitory complex through 
phosphorylation of 4E-BP1 at multiple sites (Gingras et al. 2001). In mice, it was shown that 
Akt/mTOR activation could suppress atrophy, supposedly by preventing eIF4E-4E-BP1 complex 
formation (Bodine et al. 2001b). Surprisingly, studies have shown that overexpression of the 4E-
BP1 Drosophila homolog, Thor, delays age-related muscle wasting (Demontis and Perrimon 
2010). Furthermore, Thor has an apparent role in starvation and oxidative stress resistance by 
enhancing mitochondrial activity (Zid et al. 2009; Tettweiler et al. 2005; Teleman et al. 2005). 
There is some debate that stimulation of IIS and Akt/mTOR signaling can directly 
inactivate 4E-BP1. One study found that increased insulin sensitivity in mice was correlated with 
an upregulation of ubiquitin-proteasome system components but did not increase expression of 
4E-BP1 and other factors involved in protein synthesis (dos Santos et al. 2016). Stimulation of 
inflammatory pathways and expression of cytokines like tumor necrosis factor-alpha (TNF-α) 
has been shown to repress protein synthesis by dissociating the eIF4E translational complex, 
suggesting that pathways other than IIS control translation (Tisdale 2008).  
Muscle wasting is one of many numerous physiological changes that can be traced to 




responsible for such changes remain poorly defined, despite better understanding of upstream 
signal transduction. As such, there is a distinct need to determine what effector molecules 
mediate cachectic wasting.  
Disrupted carbohydrate metabolism is a hallmark of cachexia in cancer and Type 2 
Diabetes (T2D), another disease in which cachexia commonly manifests. This disruption 
encompasses hyperglycemia, high endogenous sugar production (particularly from amino acids) 
and enhanced anaerobic recycling of glucose (Chevalier and Farsijani 2013). Given the 
pervasiveness of carbohydrate metabolism dysregulation in these diseases, it is plausible that 
participant genes in this regulation may be driving cachectic muscle wasting. 
Emerging evidence implicates the Krüppel-like Factor (KLF) family of transcription 
factors in carbohydrate metabolism – and possibly muscle wasting. Recently it was shown that 
glucocorticoids, a class of hormones that regulate glucose homeostasis, can induce muscle 
wasting by activating KLF15. Two other members of this family, KLF10 and KLF11, are notably 
upregulated in pancreatic and intestinal cancers, which are highly associated with cachexia 
(Tetreault et al. 2013; Tisdale 2002). KLF10 is thought to respond to increased glucose by 
broadly altering metabolic gene expression, in a mechanism interlinked with circadian rhythm 
(Guillaumond et al. 2010). Conversely, KLF11 is believed to bind the insulin promoter in a 
compensatory response to low intracellular glucose (Zhang et al. 2013). Altogether, these 
studies suggest a critical function of KLFs in regulating glucose homeostasis, although 
investigation into their role in muscle wasting has just begun. 
The mechanisms regulating carbohydrates are remarkably conserved in vertebrates and 
invertebrates. For example, functions closely resembling those of KLF10 and KLF11 have been 
ascribed to their Drosophila homolog, cabut (cbt) (Bartok et al. 2015; Havula et al. 2013). Due to 




model to study carbohydrate metabolism (Mattila and Hietakangas 2017). For example, 
knockdown of insulin-like peptides in Drosophila has proved to be a useful tool in modeling type 
2 diabetes (Murillo-Maldonado et al. 2011). Since altered carbohydrate metabolism is commonly 
observed in cachectic patients, broader investigations into such phenomena may shed light on 
the molecular mechanisms driving cachexia.  
Heterologous composition of skeletal muscle 
To begin identifying molecular mechanisms of cachexia, some understanding of the 
heterogeneous nature of mammalian muscle is necessary. In mammals, skeletal muscle is 
comprised of several fiber types whose ratios determine the overall functional output (Scott et 
al. 2001). These fiber types differ in metabolic profiles, mitochondrial content, structural gene 
expression, and contractile properties (Bottinelli and Reggiani 2000). Human skeletal muscle 
fiber types can be categorized as slow-twitch (Type I) or fast-twitch (Type IIa or Type IIx). Slow-
twitch fibers are characterized by high oxidative capacity and low force generation, but robust 
fatigue resistance. As such, greater proportions of slow-twitch fibers are ideal for endurance 
activities. Type IIa (oxidative-glycolytic) fibers parallel slow-twitch fibers in oxidative capacity, 
but use more readily metabolized energy sources, produce greater force, but become 
exhausted faster. Lastly, Type IIx fibers (fast glycolytic) are quickest to fatigue but yield the 
highest force, making them most suitable for short bursts of activity. Different muscles in the 
body are naturally predisposed to certain proportions of fiber types (Pette and Staron 2000). 
The soleus muscle of the lower leg, for example, is involved in long-term activities like posture 
support and walking. As such, high density of slow-twitch fibers is intrinsic to the soleus muscle. 
Variant muscle-to-muscle ratios of Type I and Type II fibers, which have distinct metabolic 
requirements, could mean that certain muscle groups are more susceptible to cachectic muscle 




Nevertheless, muscle fiber ratios in mammals are not static but highly plastic with age, 
diet, and exercise, or lack thereof (Pette and Staron 2000). This implies that fiber ratio fluctuates 
to accommodate different physiological demands. Indeed, muscle biopsies of elite athletes 
illustrate the adaptiveness of human skeletal muscle. In one champion sprint runner, biopsies 
revealed that Type IIx fibers were far more abundant than normal individuals. Moreover, the 
capacity of the runner’s Type IIx fibers to generate power eclipsed that of both untrained 
individuals and other high-level performing athletes from different disciplines (e.g. distance 
runners, competitive swimmers) (Trappe et al. 2015). Interestingly, fast glycolytic fibers, which 
can more rapidly and efficiently utilize glucose and other metabolites than their oxidative 
counterparts (Type I and IIa), may be more resistant to the negative effects of insulin resistance 
and type 2 Diabetes (LeBrasseur et al. 2010). At the other end of the spectrum, efficiency of 
cycling, an endurance activity, is positively correlated with greater percentages of Type I fibers 
(Coyle et al. 1992). These data highlight the dynamic nature of skeletal muscle fibers, but also 
extend the possibility that cachectic pathology may affect muscle fibers differently. 
Drosophila as a model for muscle wasting 
In many respects, the metabolic profiles and structural organization of Drosophila and 
human muscles are analogous, and therefore suitable for comparative studies of muscle 
wasting. The largest muscles in Drosophila, the indirect flight muscles (IFMs) and the tergal 
depressor of the trochanter (TDT, or jump muscle), have specialized functions based on their 
constituent fiber type (fibrillar and tubular, respectively). Flight muscles are outfitted with large 
quantities of mitochondria and glycogen to continuously power extended bouts of flight. 
Correspondingly, tubular-type jump muscles, which are used less frequently, are less densely 
packed with mitochondria and glycogen (Deak 1977). These muscles can be further classified 




2012a). Thus, the diversity of fiber types in Drosophila makes it a suitable model system to 
study cachectic muscle wasting. 
Drosophila is a genetically tractable model organism. One of the best examples of this is 
the GAL4/UAS expression system. In the binary GAL4/UAS system, the yeast transcriptional 
activator GAL4 is inserted under the control of a native genomic enhancer in one parental stock. 
In the other stock, the upstream activated sequence (UAS), another genetic element exported 
from yeast, is strategically placed upstream of genes of interest. Offspring of these parents will 
express GAL4 corresponding to the activity of the endogenous enhancer (i.e. if the enhancer is 
active in a specific tissue or developmental timepoint, GAL4 will exclusively be expressed 
there). Expressed GAL4 then specifically binds to the UAS, promoting transcription of the gene 
of interest (Brand and Perrimon 1993). For targeted gene downregulation, UAS-controlled, 
inverted-repeat constructs are expressed. Upon transcription, these constructs collapse to 
produce double-stranded RNA molecules that match the sequence of targeted mRNA 
transcripts and work to eliminate those transcripts via the phenomenon of RNA interference 
(Wilson and Doudna 2013).  
A GAL4/UAS model for cachexia-like muscle wasting was recently published (Kwon et 
al. 2015). In this model, yorkie (yki), a transcriptional coactivator that regulates cell proliferation 
and growth, was overexpressed in the fly midgut using the escargot (esg) GAL4 driver, which is 
active specifically in intestinal stem cells. This yielded uncontrolled cell proliferation within the fly 
midgut and induced wasting of peripheral tissues (fat body, ovary, muscles). Importantly, to 
bypass lethality in larvae, the GAL4/UAS system was modulated with a temperature-sensitive 
construct that made tumor growth permissible only at higher temperatures (Suster et al. 2004). 
In addition to systemic wasting, genes involving energy metabolism were broadly repressed in 





Here, we employ the same tumor-bearing flies (hereafter esg>ykiact) to examine the 
molecular mechanisms of cachectic muscle wasting. We aimed not only to identify novel factors 
mediating muscle wasting, but also to evaluate whether certain fiber types, due to their 





















Midgut tumors affect muscle performance 
We induced cachexia-like wasting in flies through the inducible esg>ykiact system (Fig. 
1A). In esg>ykiact flies, tumor growth is made temperature sensitive through repression of the 
GAL4/UAS system at 18°C, but can be induced by switching newly emerged adult flies to 
warmer conditions at 29°C. When neoplasia is induced, esg>ykiact tumor-bearing flies undergo 
dramatic fat body and muscle wasting (Kwon et al. 2015). We observed that temperature-
activated esg>ykiact flies have significantly shorter lifespans than controls, with the majority 
dying within the first 2 weeks of life. Based on this observation, we used 2-week old flies in most 
of our tests.  
We sought to further characterize the possible impact of the midgut tumor on the 
functionality of the indirect flight muscles (IFMs) and the tergal depressor of the trochanter (TDT 
or jump muscle). IFMs solely generate power to propel wings during flight (Lindsay et al. 2017) 
and, therefore, their functional state can be directly inferred from a test for upward flying 
mobility. Similarly, TDTs are exclusively responsible for jumping action, and their functional 
state can be determined by measuring average jumping distance. 
Cachectic esg>ykiact flies progressively lost flying ability as they aged. After two weeks of 
tumor growth, only 34% of esg>ykiact flies were able to fly (p<0.01, see two-proportion z-tests in 
Table 1), whereas 90% of age-matched control flies retained flying ability (Fig. 1C). In contrast, 
TDTs did not demonstrate exacerbated functional decline, retaining 80% of the initial jumping 
power at two weeks in esg>ykiact flies (Fig. 1D). Our results confirm that experimentally induced 
tumor-like growth in the fly midgut induces cachexia and specifically impairs the functional state 
of somatic muscles. Notably, IFMs and TDTs have different response rates, the former being 




Flight and jump muscles respond differently to tumor presence 
 To gain insight into the functional differences observed for , we evaluated biochemical 
differences between these two muscle types. IFMs are very energetically active due to their 
demanding functional role to power flight, which is reflected by high mitochondrial content and 
stored glycogen levels (Deak 1977). We tested mitochondrial function with an enzymatic assay 
of succinate dehydrogenase (SDH) activity (Pearse 1972). SDH is a protein complex located 
within the inner mitochondrial membrane which plays key roles in both the citric acid cycle and 
electron transport chain (Hederstedt and Rutberg 1981). In this assay, both control and young 
esg>ykiact flies, before tumor induction, have IFMs that are strongly positive for SDH activity. In 
stark contrast, TDTs, which become activated for contractions only occasionally, are negative 
for SDH activity and glycogen (Fig. 2A, D). After two weeks, esg>ykiact flies displayed SDH-
negative IFM fibers (Fig. 2A). The lack of SDH activity is indicative of dysfunctional mitochondria 
and ultimately results in fiber degeneration. Indeed, additional examination of SDH-negative 
fibers often revealed signs of fiber integrity breaches, picnotic nuclei, and alterations in 
myofibrilar striation pattern (not shown). The SDH assay revealed that approximately 27% of 
IFM fibers from two-week old esg>ykiact flies lacked functional mitochondria (Fig. 2B). The 
occurrence rate of IFM degeneration was high, as we observed degenerate fibers (i.e., at least 
one degenerate fiber) in 37% of two-week old esg>ykiact flies (p<0.05, see two-proportion z-tests 
in Table 2), but no degeneration was observed in the control group (Fig. 2C).  
IFMs store large quantities of metabolically available glucose in the form of glycogen to 
power extended periods of flight (Sacktor 1955). We hypothesized that glycogen loss could be 
responsible for impaired mitochondrial function in esg>ykiact flies. In two-week old esg>ykiact 
flies, 46% of fibers assessed lacked glycogen. We observed glycogen loss in 10% of fibers in 
two-week old control flies (Fig. 2E). Incidence of glycogen depletion was evident, as 60% of 




20% of control flies (Fig 2F). Where one fiber was glycogen-deficient in esg>ykiact IFMs, the 
remaining fibers were similarly lacking glycogen in the same fly. 
Unlike IFMs, TDTs store very little glycogen (Deak 1977). Interestingly, in the cases of 
total glycogen loss in IFMs of two-week old esg>ykiact flies, we observed unusual accumulation 
of glycogen within TDTs (Fig. 2D). This observation serves as another remarkable indication 
that IFMs and TDTs have different responses to tumor presence. Our data suggest that IFMs 
undergo metabolic changes, resulting in depletion of glycogen stores, which might trigger 
mitochondrial damage and subsequent death of IFM fibers. 
Since TDTs do not demonstrate readily detectable SDH activity, we analyzed another 
marker of muscle degeneration – loss of staining for polymerized actin (F-actin), a major 
component of the contractile apparatus. For this, we probed for the absence of F-actin in TDT 
fibers. To confirm that regions lacking F-actin were indeed once fibers, we only counted those 
regions in which cell membranes could be visualized (Fig. 3A). Impressively, less than 1% of 
TDT fibers in both two-week old control and esg>ykiact flies were ranked as degenerate (Fig. 
3B). Of the flies assessed, we observed at least one degenerate fiber in 13% of control flies and 
21% of esg>ykiact flies (Fig. 3C). Since F-actin assessment can only account for fibers that are 
in the process of dying, we also searched for changes in the numbers of live TDT fibers (since 
Drosophila muscles are naturally lacking regeneration mechanisms). When comparing the 
median numbers of counted fibers between control and esg>ykiact flies, we did not observe any 
significant difference (Fig. 3D). These results, in contrast with IFM data, support the notion that 
TDTs are less susceptible to the effects of the experimental gut tumors.  
Altogether, our data demonstrate that the basis for differential functional response of 




demands. Another potential factor could be in the intrinsic, fiber-specific differences in 
carbohydrate control, characteristic of each of these muscles.  
Transcriptional changes in muscles of cachectic flies 
To determine molecular factors that might mediate muscle degeneration in esg>ykiact 
flies, we analyzed whole-transcriptome changes in IFMs and TDTs collected one week after 
experimental tumor onset, at the midpoint of degenerate IFM fiber development. Total RNA 
extracted from dissected IFMs and TDTs was submitted for next-generation sequencing. 
Overall, the amount of total RNA extracted from IFMs was relatively low, but the relative 
abundance of transcripts in those samples was maintained as expected, meaning genes with 
well-known expression profiles maintained those profiles (not shown). This includes muscle 
structural genes, such as actin and myosin heavy chain, as well as mitochondrial and metabolic 
genes involved in glycolysis and respiration. To better visualize the relevant expression levels 
between IFMs and TDT muscles, we normalized expression of each gene by the levels of Mef2, 
a pan-muscular gene that is moderately expressed from the early stages of muscle 
development and throughout adulthood (Bour et al. 1995; Bryantsev et al. 2012a). Muscles from 
one-week old control and esg>ykiact flies were analyzed in parallel.  
Next, we used RNAseq data to identify critical regulators that might be responsible for 
IFM sensitivity to tumor presence. We selected two candidate genes, cabut (cbt) and Thor, 
whose expression elevated in the presence of experimental tumors (Fig. 4A). Endpoint PCR 
also confirmed the expressional changes of our genes of interest in esg>ykiact flies (Fig. 4B). We 
selected both genes based on their conserved sequences and function in humans. Reiterating, 
Thor is strictly conserved across all eukaryotes and plays a central role, downstream of IIS, in 
regulating translation initiation (Gingras et al. 1999). Most similar to cbt are the Krüppel-like 
factor (KLF) proteins KLF10 and KLF11 (Muñoz-Descalzo et al. 2007), which both have roles in 




Effects of cbt and Thor overexpression in flight muscles  
To explore the role of cbt and Thor in muscle degeneration, we overexpressed cbt and 
Thor with the GAL4 driver under the control of the flightin (fln) enhancer (Bryantsev et al. 
2012b). Critically, fln expression is robust and localized exclusively to the IFMs, where it is 
required for myosin thick filament assembly (Fig. 5A) (Reedy et al. 2000). Expression of fln 
begins in the late pupal stages and continues throughout adulthood, although its expression 
weakens with age (Vigoreaux et al. 1993). We first evaluated the functional impact of cbt or 
Thor overexpression on IFMs. For this, we drove expression of wild-type cbt and a consitutively 
active Thor, mutated at a key regulatory phosphosite. Strikingly, fln>cbt adults were entirely 
unable to fly, from the youngest age (p<0.01, Table 1), which suggested that cbt has an impact 
on IFM physiology. In contrast, 75.3% of fln>Thoract flies (p=0.14, Table 1) retained flying ability 
at two weeks old (Fig. 5B). Given the dramatic functional loss observed in IFMs, we selected cbt 
for further analysis. 
cbt overexpression induces morphological and biochemical changes in flight 
muscles similar to those observed in cachectic flies 
 Based on the flight test results, we strongly suspected that the IFMs of fln>cbt flies would 
have extensive mitochondrial dysfunction and glycogen depletion. In two-day old fln>cbt flies, 
0.5% of IFM fibers were degenerate. After two weeks, the proportion of degenerate IFM fibers 
substantially increased to 38.8%, mirroring the rate of fiber degeneration observed in esg>ykiact 
flies (Fig. 6B). However, 90% of two-week old fln>cbt flies (p<0.01, Table 2) showed some signs 
of degeneration, greatly surpassing the incidence seen in esg>ykiact flies (Fig. 6C).  
Impressively, glycogen stores in two-day old fln>cbt flies were completely depleted, 
while all IFM fibers of the control group had glycogen. By two weeks, only 6.1% of IFM fibers of 
control flies lacked glycogen. We observed that 22.9% of IFM fibers of two-week old fln>cbt flies 




recovery is that fln-GAL4 expression, which drivers cbt expression in this system, weakens with 
age. The gradual dampening of cbt levels would allow for some IFM fibers to return to normal 
metabolic conditions. Despite this, we still observed glycogen-deficient fibers in 100% of fln>cbt 
flies, both at two-days and two-weeks old (Fig. 6F) (p<0.01 and p<0.05, respectively; Table 2). 
We observed incidences of glycogen loss in 73.3% of two-week old control flies. It is well known 
that glycogen levels diminish following activity, or increase after eating (Deak 1977). The high 
incidence of glycogen loss in control flies is likely due to this innate variability in glycogen levels. 
These results indicate that targeted overexpression of cbt within the IFMs has dramatic 
effects on the ability to retain vital glycogen stores. While the magnitude and prevalence of SDH 
activity loss and glycogen loss is more pronounced in fln>cbt flies, these results point to a 
shared condition of a metabolic dysregulation within the IFMs of esg>ykiact and fln>cbt flies, 
coinciding with increased rates of muscle fiber degeneration. 
Characteristic morphological changes of cachectic and cbt-overexpressing flight 
muscles 
 Thus far we have shown that the IFMs of esg>ykiact flies and fln>cbt flies suffer similar 
loss of functionality, mitochondrial activity, and glycogen content. In addition to this, SDH 
analysis revealed a unique morphological feature that was shared by both experimental groups 
– distinct perforations throughout IFMs (Fig. 7A, 7D). We saw perforations only in IFMs – 
typically before the onset of the massive fiber degeneration. Perforations were usually observed 
in one-week old esg>ykiact flies, while they were more frequently observed in two-day old fln>cbt 
flies. The unique nature of the perforated phenotype strongly links the deleterious effects of cbt 
overexpression to the muscle degeneration seen in esg>ykiact flies. Despite this, the exact 
nature of this phenomenon is unknown.  
We attempted to further characterize the perforations by assessing both the 




staining did not show any discernible mitochondria loss, nor did α-dlg staining show t-tubule 
presence within the perforations (Fig. 7B, 7C). Furthermore, we probed for the formation of poly-
ubiquitin aggregates, a sign of heightened autophagy (Morimoto et al. 2015), but we did not 
observe any aggregates in control or esg>ykiact flies (not shown). Higher resolution analysis with 
electron microscopy will  be performed to confirm the nature of the damage where these 
methods could not, in addition to highlighting the similarities and differences between the 
perforations of esg>ykiact and fln>cbt flies. Since neither t-tubules nor mitochondria are present 
in the perforations, we propose that accumulation of excess water into the cytosol may be the 
causitive factor. 
cbt overexpression does not harm jump muscles, and a possible role of cbt in 
jump muscle fiber specification 
 Our next step was to characterize the effects of cbt overexpression on TDTs. To do this, 
we used the GAL4 driver made with the enhancer elements of muscle-specific gene Actin 79B 
(Act79B-GAL4), which is active in TDTs, but not IFMs (Bryantsev et al. 2012a). Like fln-GAL4, 
Act79B-GAL4 expression begins in the late stages of muscle development and persists 
throughout adulthood (Fyrberg et al. 1983). To our surprise, overexpression of cbt in TDTs was 
not deleterious, but resulted in extensive muscle hypertrophy (Fig. 8A). When compared to 
control flies, the average fiber number and surface area of Act79B>cbt flies increased by 58.7% 
and 56.3%, respectively (Fig. 8B). At the same time, we did not observe any significant 
difference in jumping ability between Act79B>cbt and control flies (Fig. 8C). TDTs respond in an 
altogether different manner to cbt overexpression than IFMs. Therefore, it is possible that cbt is 
part of the molecular mechanism controlling selective response of different muscle types (flight, 







cbt induces its deleterious effects independent of the insulin pathway  
Currently, the regulatory mechanisms controlling the cbt gene are poorly understood. 
Therefore, we wanted to find a place for cbt within the cell signaling network of the IFMs. The 
most immediate candidate for testing was the IIS pathway. Given the well-established role of IIS 
in muscle mass maintenance (Meek et al. 1998; Goldspink 1999) and the putative role of IIS 
dysregulation in the cachectic phenotype of esg>ykiact flies (Kwon et al. 2015), we decided to 
probe the effects of IIS suppression on IFMs. For that, we overexpressed a dominant-negative 
K1409A mutant of the insulin receptor (InR) that lacked tyrosine kinase activity with the GAL4 fln 
driver. Only 46.2% of fln>InRDN flies were capable of upward flying at two days old, and by two 
weeks, all were unable to fly (Fig. 9A) (p<0.01 at both timepoints, Table 1). As expected, IIS 
suppression had harmful effects on mitochondrial function and glycogen storage in IFMs. 
Surprisingly, however, mitochondrial damage was substantially less pronounced than those 
caused by the midgut tumor in esg>ykiact flies. In two-week old fln>InR DN flies, only 6.8% of 
fibers fell under the degenerate category (Fig. 9B). Despite this, we observed significant 
glycogen loss in fln>InR DN flies, which supports the notion that the IIS pathway was indeed 
repressed in these flies. In two-day old fln>InR DN flies, 46.9% of IFM fibers were glycogen-
deficient, but by two weeks glycogen levels had recovered to 18.8% (Fig. 9D). Again, this is 
likely due to diminishing fln-GAL4 expression as the flies age.  
Since we did observe significant functional impairment and morphological damage as a 
result of IIS suppression, we proceeded with molecular analysis. To do this, we extracted RNA 
from the IFMs of fln>InR DN and fln>cbt flies and compared the effects on both cbt and Thor 
expression. Thor is typically repressed when IIS is active (Gingras et al. 1998). Accordingly, 
Thor expression increased in fln>InR DN flies. Interestingly, Thor was upregulated in fln>cbt flies, 




genetic activator of Thor, but the nature of the regulation (direct or indirect) is unclear. 
Moreover, activation of cbt itself does not seem to depend on the IIS pathway (Fig. 10B). 
Surveying the transcriptome of cbt-overexpressing flight muscles for potential 
effectors of muscle wasting 
 Having characterized the deleterious effects of cbt on IFMs, we sought to identify 
commonly regulated genes between esg>ykiact and fln>cbt flies. Particularly, we were interested 
in genes that might regulate energy metabolism, given the extensive glycogen loss observed in 
both groups. For this, we extracted RNA from the IFMs of one-week old control and  fln>cbt flies 
for next generation sequencing. We then analyzed annotations of genes that had significantly 
altered expression in both esg>ykiact and fln>cbt flies. Our analysis found no specific enrichment 
in genes of a particular function or process in esg>ykiact flies. Nonetheless, we found that genes 
associated with mitochondrial ATP synthesis were among those with the most significant 
presence in fln>cbt flies. We also observed upregulation of 6 genes involved in synthesis of 
carbohydrate derivatives (Table 3). 
  Since the enrichment analysis was limited, we again normalized our results to the 
expression of Mef2 and compared the expression across all groups. A small set of candidate 
genes was manually extracted from this data (Table 4). The first of these candidates, Cyp4p3, 
an oxidoreductase, was commonly upregulated. It is suggested that oxidoreductases, which are 
the primary generators of reactive oxygen species, may drive oxidative stress in mitochondria 
(Kussmaul and Hirst 2006). Interestingly, TotA, a gene that has a putitive role in oxidative stress 
response, was downregulated (Ekengren et al. 2001). Finally, we determined that target of brain 
insulin (tobi), an O-glycosyl hydrolase, was upregulated. Glycosyl hydrolases are critical for 
enzymatic breakdown of polysaccharides such as glycogen (Davies and Henrissat 2015). 
Future work will evaluate whether aberrant expression of these genes can sufficiently induce 





In this study, we show that yki-driven midgut neoplasia impairs somatic muscle function 
and causes muscle fiber degeneration. While some of our data strengthen previously reported 
results (Kwon et al. 2015), we further describe selectivity in functional impairment of indirect 
flight muscles (IFMs) over the jump muscles (TDTs). Why would these two muscle types 
respond differently to tumor presence? We think that the reason lies in the difference of 
metabolic activity characteristic for these muscles. IFMs, like type I muscle fibers in humans, 
depend on oxidative phosphorylation for their main source of energy. This is evident by high 
density of mitochondria and high levels of SDH activity. In contrast, TDT muscle contains few 
mitochondria and low SDH activity. The downside of high mitochondrial content seems to be the 
constant high demand for oxidative phosphorylation substrates (e.g. glucose, fatty acids), even 
during periods of rest when no active work is being done. The high resource expenses could be 
a decisive factor driving muscle size reduction seen in mammals and humans upon fasting or 
prolonged muscle disuse (Hikida et al. 1989; Bouché et al. 2004). Mammalian fibers are highly 
plastic and can undergo reversible size reduction known as atrophy, but under chronic 
conditions the overall number of highly oxidative fibers in skeletal muscles dwindles. For 
example, fewer Type I fibers can be seen in diabetic patients and animal models of diabetes 
(Oberach et al. 2006; Song et al. 1999). Fiber-type specific atrophy has been also reported in 
response to cancer, but the type of responding fibers depends on specifics of cancer etiology. 
Usually, less oxidative Type II fibers are reported to atrophy in cancer patients (Mendell and 
Engel 1971; Acharyya et al. 2005).  
In our fly model, instead of fiber atrophy we readily detect a more severe and irreversible 
response – fiber degeneration (i.e. death). This is because Drosophila skeletal muscles lack the 




fact comes as a strong advantage, since without repair we receive a faithful, quantifiable record 
of muscle response to an experimental condition. Fiber degeneration is a more common 
process in mammalian muscles undergoing atrophy, but it becomes significantly masked by an 
ongoing regeneration process that involves satellite cells (Borisov et al. 2001). Damage and 
elimination of oxidative capacity in IFMs is reminiscent of the disappearance of type I fibers 
during diabetes (Oberach et al. 2006). Why is this trend of oxidative fiber perturbations not 
explicitly reported in cancer studies? One of the reasons could be in the specifics of our cancer 
model. As described before, esg>ykiact tumors induce systemic hyperglycemia, which is 
characterized by high levels of circulating sugars and inhibition of the IIS pathway (Kwon et al 
2015). This condition is highly reminiscent of that conferred by type 2 diabetes (insulin-
independent), which is why the response from oxidative muscle fibers in our model and diabetic 
patients is similar. Notably, hyperglycemia is commonly associated with some tumors, 
especially originating from the gastrointestinal tract (Tayek, J.A., 1992). There is a scarcity of 
information of how hyperglycemia may influence oxidative fiber loss, but our study certainly 
predicts such a link. 
 One interesting aspect of our results is the atypical deposition of glycogen to the TDTs 
in cachectic flies. One possible explanation is that, in acute cases, TDTs compensate for the 
physiological burden of hyperglycemic conditions by accumulating glycogen. Interestingly, 
higher amounts of type IIx fibers are seen in type 2 diabetes patients (Mogensen et al. 2007). 
Type IIx fibers have higher glycogen content and glycolytic activity, and it is suggested that they 
are naturally resistant to the effects of insulin resistance and type 2 diabetes (Lebrasseur et al. 
2010). Thus, accumulation of glycogen in TDTs may represent a physiological mechanism for 
regulating circulating sugar comparable to increasing amounts of type IIx fibers in type 2 
diabetes patients. Certainly, these data underscore the differences in carbohydrate control 




TDTs would further elucidate the possible mechanisms by which TDTs and their mammalian 
counterparts circumvent wasting and metabolic dysregulation. 
We were particularly interested in identifying genetic factors that are involved in the 
different response demonstrated by IFMs and TDTs in the presence of gut tumors. Through 
comparative gene expression analysis, we identified the evolutionarily conserved transcription 
factor, cbt, as one of the candidates. Notably, cbt overexpression in IFMs, but not TDTs, 
induced functional impairment, mimicking the fiber-specific susceptibility of esg>ykiact flies to 
tumor presence. Our findings of extreme IFM glycogen depletion suggest that cbt does 
modulate carbohydrate control. Indeed, ubiquitous knockdown of cbt induces sugar intolerance, 
suggesting a role in carbohydrate metabolism (Havula et al. 2013). Considering its role in sugar 
tolerance, cbt induction in the hyperglycemic esg>ykiact flies may represent a compensatory 
response gone too far (i.e. IFM death). 
The most surprising similarity between cbt-overexpressing (fln>cbt) and cachectic 
(esg>ykiact) IFMs was the characteristic morphology featuring hollow formations within muscle 
fibers (which we termed ‘perforations’). These features were detected at the time points 
preceding mass fiber degeneration. We are not positive that the perforations originate from 
swollen membranous structures, as these perforations stain neither for mitochondria nor t-tubule 
cisternae markers. Furthermore, nuclei were localized to the peripheries, wholly within the 
perforations. Based on our combined analysis, we suspect that sarcoplasmic swelling may 
explain the perforations. One possible explanation for the swelling could be the cells adjusting 
osmolarity to normal physiological levels in response to an excess of an unknown metabolite in 
the cytosol. Given the aberrations in carbohydrate metabolism, such an accumulation of 
metabolites is plausible. Hypo-osmotic swelling poses a significant threat to cell membrane 
integrity, and as such, may contribute to IFM death (Pietuch et al. 2013). Further investigation, 




Our finding that cbt overexpression in the TDTs induced significant muscle hypertrophy 
was unexpected yet underscored the contrast between IFMs and TDTs. Unlike mammalian 
skeletal muscle, fiber number and composition are immutable in adult Drosophila somatic 
muscles (Piccirillo et al. 2014). Thus, our results strongly suggest that cbt plays a critical role in 
TDT myogenesis. One report that stimulation of TGF-β signaling increases TDT fiber number 
strongly support this notion as well (Jaramillo et al. 2009). Further supporting its developmental 
role, cbt was shown to be a required factor for dorsal closure (Muñoz-Descalzo et al. 2005). 
Differential gene expression analysis would be instrumental in determining the downstream 
effectors of this developmental role.  
Collectively, our findings emphasize that differing metabolic requirements dramatically 
influence the susceptibility of fiber types to muscle wasting. Metabolically active muscles, such 
as IFMs, are more acutely affected than the sporadically active TDTs. We also present strong 
evidence implicating cbt as a critical factor mediating cachectic muscle wasting, but little is 
known about the gene targets downstream of cbt. However, we have identified several genes 
that may be responsible. Our gene enrichment analysis suggests that genes involved in the 
biosynthesis of carbohydrate derivatives are differentially regulated, which may explain our 
hypothesis that an accumulation of metabolites in the cytosol induces hypo-osmotic stress. The 
upregulation of the oxidoreductase Cyp4p3 in both esg>ykiact and fln>cbt flies is particularly 
interesting, as oxidoreductases are suspected drivers of oxidative stress (Kussmaul and Hirst 
2006). We also found that tobi, an enzyme involved in the breakdown of polysaccharides (like 
glycogen) was commonly upregulated (Davies and Henrissat 2015). Attenuation of tobi 
expression by RNAi knockdown may protect glycogen reservoirs from depletion. 
Thus, our study provides important clues in the search of physical effectors driving 





INTEGRATION OF THESIS RESEARCH 
In this work, we have identified potential causes, at the molecular scale, of cachexia-like 
muscle wasting in Drosophila. We anticipate, given the conserved sequence and function of cbt, 
that our findings will hold relevance in studies of muscle wasting in murine and human models. 
In pursuit of the molecular mechanisms underlying cachexia, various fields of biology 
were incorporated. This project was fundamentally rooted in organismal biology, genetics, 
histochemistry, bioinformatics, and molecular biology. Drosophila researchers are outfitted with 
potent tools, like the GAL4/UAS system, to modulate the expression and function of genes. 
Without these tools, this study would certainly not have been possible. Moreover, the use of 
PCR, next-generation sequencing, and bioinformatic techniques was invaluable in our search 
for genes of interest. Histochemical techniques such as the SDH and PAS assays for 
mitochondrial activity and glycogen presence were critical to characterize the detrimental effects 
of cbt on flight muscles. Furthermore, our understanding of mammalian skeletal muscle 
physiology allowed us to draw conclusions that may provide insight into the etiology of fiber-
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MATERIALS AND METHODS 
Transgenic Flies and Drosophila Stocks. Transgenic fly stocks to regulate gene 
expression are shown in Table 5; In driver lines, the gene GAL4, a yeast transcriptional 
activator, is inserted under control of native regulatory elements enabling its expression in 
different tissues or developmental times. Within these tissues, GAL4 specifically binds to the 
enhancers containing the upstream-activated sequence (UAS), exported from yeast and 
strategically placed upstream of genes of interest, for ectopic gene transcription. For targeted 
gene downregulation, UAS-controlled constructs express double-strand RNA molecules 
matching the sequence of targeted transcripts to eliminate them via the phenomenon of RNA 
interference. All stock lines were maintained at room temperature. For most crosses, virgin 
females were collected regularly from the GAL4 stocks. Crosses were made using GAL4 
females and UAS or control males. Transgenic flies were reared in separate incubators kept at 
18°C, 25°C, and 29°C, or at room temperature. esg>ykiact crosses began at 18°C, and virgin 
adult flies were relocated to 29°C to induce neoplasia. Crosses involving fln-GAL4 and Act79B6-
GAL4 were maintained at 29°C. All aging of flies was done at 29°C and flies were moved to 
fresh food twice per week. 
Flight and Jump tests. Newly emerging flies were collected and reared at 29°C for 2 days, 1 
week, and 2 weeks. At time of testing, flies were allowed to acclimate to room temperature for 
30-60 minutes. Individually, flies were released into the testing chamber (lit from above and 
partioned into regions designated as Up, Horizontal, Down, and Null/Nonflying). The landing 
location of each fly was then recorded. After tests, flies were knocked out at cold temperature 
(4°C) and recollected for histological analysis. For jump tests, wings were clipped and flies were 




where jump distance could be marked (start and end points, then measured). If necessary, flies 
were coaxed to jump with light touches from a paintbrush.  
Cryosectioning. Flies were snap-frozen in liquid nitrogen and sectioned on a Leica CM1850 
cryostat. Section thickness for immunofluorescent analysis was maintained at 7µm, for 
histochemistry – 14 µm. Serial sections were collected on microscope slides and air-dried. 
Immunofluoresecence staining. ¥ Sections (7 µm) were fixed in 3.7% formaledehyde and 
then rinsed in 1X Phosphate Buffered Solution (PBS). After fixation, sections were 
permeabilized in a solution of 1X PBS containing 1% Triton X-100. Alexa Fluor 488 phalloidin 
was used to stain F-actin (1:1000), and DAPI was used for DNA staining. Immunostaining 
against alpha and beta integrins was done using DK.1A4 and CF.6G11 monoclonal antibodies 
(1:100), which were obtained from the Developmental Studies Hybridoma Bank (DSHB) 
(DK.1A4 and CF.6G11 were originally deposited to DSHB by Brower, D.). To stain t-tubules, 
4F3 α-Dlg antibody was used (DSHB, 1:100). For mitochondrial staining, Alexa Fluor 568 
Streptavidin (S11226) was used, owing to high biotinylated protein moetries present in the 
mitochondrial matrix and involved in carboxylation of organic acids (Praul et al. 1998). 
Succinate Dehydrogenase (SDH) Assay. We adopted the protocol published by Deak in 
1977. Fresh sections (14 µm) were incubated in a solution containing sodium succinate (500 
mM), Nitro-BT (4 mg/ml), Tris-HCl pH 7.4 (0.2 M), MgCl2 (50 mM), H2O, and sodium azide (100 
mM). After 5 minutes of incubation, sections were rinsed in 1X PBS. Sections were then fixed in 
3.7% formaldehyde, rinsed in 1X PBS, and mounted on slides with a coverslip. 
Periodic acid-Schiff (PAS) staining. Standard PAS histochemical protocol was used. 
Sections (14 µm) were fixed in 3.7% formaldehyde and then rinsed in 1X PBS. After fixation, 




Following oxidation, sections were incubated in Schiff’s reagent for 15 minutes, then rinsed in 
distilled water for 5 minutes, dried, and mounted. 
Microscopy. For fly collection, freezing, and muscle dissections, a Leica MZ75 dissecting 
microscope was used. For imaging of SDH and PAS assays, a Zeiss Axio Imager M2 was used. 
Fluorescence micrographs were taken on a Zeiss LSM 700 Confocal microscope.  
Muscle Dissections. Muscles were dissected using syringe needles (23G and 27G) under a 
dissecting miscroscope. Adult flies collected for dissection (all reared at 29°C for 1 week) were 
moved to TissueTek OCT and then washed three times in 1X PBS solution. Fly thoraces(8 for 
IFMs and up to 20 for TDTs) were split in 1M sucrose and flight muscles were dissected and 
relocated into the lysis RLT buffer supplied by the Qiagen RNeasy Mini Kit. Dissected flight 
muscles were stored at -20°C until ready for RNA purification. 
RNA purification. Homogenization of dissected muscle tissue was performed with washed 
glass beads (0.5mm) in RLT buffer. RNA purification was done using the RNeasy Mini Kit 
(Qiagen) protocol. Final concentrations were measured with the Thermo Scientific NanoDrop 
Lite spectrophotometer. Typically, we obtained 100-200 ng of total RNA per sample. Samples 
for RNA-seq were then stored at -80°C until shipped. Samples for cDNA synthesis were stored 
at -20°C. 
PCR and cDNA synthesis. All PCRs were performed used the LabNet MultiGene OptiMax 
thermocycler with Clontech Advantage 2 polymerase mix. cDNA synthesis was performed with 
random DNA hexamers (50 µM), dNTPs (10 mM), 5X FS Buffer, DTT (0.1 M), and Superscript II 
reverse transcriptase (Invitrogen). After synthesis, samples were diluted 1:5 in 1X TE buffer. 
Next-Gen Sequencing. Total mRNA samples obtained from dissected muscles were 




using Illumina HiSeq 2500. Sequencing parameters used: 30 million single-end reads averaging 
100 bp. Post-run analysis was performed using the Galaxy online bioinformatics platform 
(usegalaxy.org). Alignment of unique reads to the D. melanogaster genome (flybase.org) was 
performed using RNA Star, and CuffLinks was used to map data to all known transcript isoforms 
and for normalization of read counts. Results were further normalized to the expression of 
muscle-specific Mef2 gene, stably expressed in all muscle types. Gene alignment for secondary 
analysis to probe commonly and differentially regulated genes was done with transcriptome 
mapping tool Salmon. Statistical divergence between samples was analyzed with DEseq2.  
Statistics. For jump muscle measurements (fiber number, surface area), mean measurements 
and standard deviations could be calculated. For binary data such as flight tests and incidence 
rates, two-proportion z-tests were used to evaluate statistical significance (for further information 
on the method, see http://influentialpoints.com/Training/z-test_for_independent_proportions-
principles-properties-assumptions.htm). In z-tests, experimental groups were always compared 
against age-matched, isogenic controls (e.g. two-day old esg>+ would be paired against two-
day old esg>ykiact flies). To calculate z-values, the following formula was used: 
z =  
(p1 − p2)









  p1 and p2 are the two sample proportions 
  n1 and n2 are the two population sizes 
  p is the estimated true proportion under the null hypothesis equal to   








FIGURES AND TABLES 
 
 
Figure 1: esg>ykiact flight muscles are more susceptible to loss of function than jump 
muscles (A) Dissected midguts of control (esg>+) and neoplasia producing esg>ykiact. GFP expression 
is driven in intestinal stem cells by esg-GAL4,UAS-GFP. Note dramatic enrichment of GFP-positive cells 
in esg>ykiact midguts. (B) Survivorship plot over 8 weeks. Control and esg>ykiact are represented by green 
and purple lines, respectively. (C) Assay testing functional state of flight muscles, shown as percentage of 
control (green) and esg>ykiact (purple) flies able to fly upwards. See Table 1 for statistical analysis. (D) 
Assay testing functional state of jump muscles, jumping distance (mm) of control (green) and esg>ykiact 











Figure 2: Mitochondrial damage and glycogen loss in esg>ykiact flight muscles (A) 
Sectioned thoraces stained by histochemistry to show succinate dehydrogenase (SDH) activity; Note that 
IFMs are strongly positive for SDH (dark purple/blue staining); scale = 100µm (B) Quantification of SDH 
positive (living) and SDH negative (dead) flight muscle fibers. Total fibers assessed in parentheses. (C) 
Incidence of flies with at least one SDH-negative flight muscle fiber. 15-20 flies were assessed per group. 
See Table 2 for statistical analysis. (D) Sectioned thoraces stained for glycogen content with periodic acid 
Schiff (PAS) assay; IFMs, not TDTs, are normally positive for glycogen (pink staining), however glycogen-
positive jump muscles can be seen in esg>ykiact flies (indicated by asterisk, *); scale = 100µm (E) 
Quantification of flight muscle fibers positive and negative for glycogen in PAS assay. Total fibers 
assessed in parentheses. (F) Incidence of flies with at least one flight muscle fiber lacking glycogen. 15 












Figure 3: esg>ykiact jump muscles do not degenerate (A) Example of a degenerate jump muscle 
fiber (arrows), which can be detected by the lack of F-actin positive staining (green) and nuclei (blue) 
Individual fibers within the TDT are revealed by immunostaining of the transmembrane surface integrins 
(red); scale = 50µm (B) Quantification of degenerate jump muscle fiber counts by presence/absence of F-
actin. Control (green) and esg>ykiact (purple). Number of fibers assessed are in parentheses. (C) 
Incidence of degenerate jump muscle fibers in two-week old flies. (D) Quantification of living jump muscle 
















Figure 4: Identification of two candidate genes, cbt and Thor (A) Relative mRNA expression 
(normalized to Mef2 levels) of candidate genes from dissected flight muscles (top graph) from dissected 
jump muscles (bottom graph), as revealed by next-gen sequencing. (B) Confirmation of cbt and Thor 
overexpression by endpoint PCR of cDNA synthesized from extracted flight muscles. Top represents 














Figure 5: cbt overexpression eliminates flight muscle functionality (A) Flight muscle specific 
expression pattern of the fln driver, as shown by β-galactosidase expression from LacZ transgene (red); 
F-actin and nuclei are counterstained by green and blue, respectively; scale = 50µm (B) Percentage of 
control (gray; fln>+), cbt-overexpressing (green; fln>cbt) and Thor-overexpressing (blue; fln>Thor) flies 
















Figure 6: Extensive mitochondrial damage and glycogen deficiency in fln>cbt flight 
muscles (A) Sectioned thoraces stained by histochemistry to show succinate dehydrogenase (SDH) 
activity; scale = 100µm (B) Quantification of SDH positive (living) and SDH negative (dead) flight muscle 
fibers. Total fibers assessed in parentheses. (C) Incidence of flies with at least one SDH-negative flight 
muscle fiber. 19-26 flies were assessed per group. See Table 2 for statistical analysis. (D) Periodic Acid 
Schiff assay (glycogen stain) images; scale = 100µm (E) Quantification of flight muscle fibers positive and 
negative for glycogen in PAS assay. Total fibers assessed in parentheses. (F) Incidence of flies with at 


























Figure 7: Characterization of perforations in flight muscles of esg>ykiact and fln>cbt flies. 
(A) Magnified view of a transverse section of dorsal-ventral flight muscles showing varying severity of 
morphological changes of esg>ykiact flies. ykiact transgene was induced for 7 days; scale = 50µm (B) 
Staining for mitochondrial biotin with streptavidin (red) to reveal mitochondria in flight muscles; scale = 
20µm (C) t-tubule immunofluorescence staining with anti-Dlg antibody (red); scale = 10µm (D) SDH assay 















Figure 8: cbt overexpression within jump muscles induces hypertrophy while sparing 
jumping ability (A) Morphology of control (Act79B6>+) and Act79B6>cbt jump muscles. Individual 
fibers within the TDT revealed by immunofluorescence staining with α and β-integrin antibodies (red) and 
costained for F-actin (green) and nuclei (blue); scale = 50µm (B) Quantification of living jump muscle fiber 
counts. Values shown are means ± SDs. (C) Quantification of jump muscle surface area (µm2). Values 














Figure 9: Suppression of insulin signaling impairs flight muscle function, glycogen 
storage, and mitochondrial activity (A) Percentage of control flies (fln>+) and experimental flies 
overexpressing a dominant-negative insulin receptor (fln>InRDN) able to fly upward. See Table 1 for 
statistical analysis. (B) Quantification of SDH positive (living) and SDH negative (dead) flight muscle 
fibers. Total fibers assessed in parentheses. (C) Incidence of flies with at least one SDH-negative flight 
muscle fiber. 20 flies were assessed per group. See Table 2 for statistical analysis. (D) Quantification of 
flight muscle fibers positive and negative for glycogen in PAS assay. Total fibers assessed in 
parentheses. (E) Incidence of flies with at least one flight muscle fiber lacking glycogen. 15 flies were 














Figure 10: cbt is not under regulation by the insulin/insulin-like signaling pathway  
(A) Gene expression of cbt and Thor shown by endpoint PCRs of cDNA synthesized from extracted flight 
muscles. Top represents genotype, Left represents amplification target. Amplification of 18S rRNA was 
used as loading control. (B) Proposed place for cbt in the cell signaling network. Novel finding is indicated 

















Table 1. Two-proportion Z-test analysis performed on all flight test results, comparing experimental 














Table 2. Two-proportion Z-test analysis performed on all fiber count incidences (SDH and glycogen 











Table 3. Biological functions overrepresented among genes altered in IFMs by midgut tumors 














Table 4. Candidate genes for further analysis, selected from transcriptome data based on their 
















Table 5. List of transgenic lines and their genotypes used in this study with the source 
and ID number of the lines, if applicable. 
ID Source Line Genotype 
3605  w1118 w[1118] 
 Courtesy of 
Young Kwon, 
Perrimon Lab 
(Kwon et al. 
2015) 
esgTS-GAL4 w[*]; P{w[+mW.hs]=GawB}NP5130 P{w[+*]=UAS-
GFP.U}2; P{w[+mC]=tubP-GAL80[ts]}2¥ 




 Courtesy of 
Young Kwon 
(Kwon et al. 
2015) 
UAS-ykiact w[*]; P{w[+mC]=UAS-yki.S111A.S168A.S250A}¥ 
43373 BDSC UAS-cbt w[*]; P{w[+mGS]=GSV1}cbt[C480] ush[C480] 
24854 BDSC UAS-Thoract w[*]; P{w[+mC]=UAS-Thor.LL}s/TM6C, cu[1] Sb[1] 
8252 BDSC UAS-InRK1409A y[1] w[1118]; P{w[+mC]=UAS-InR.K1409A}2 
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